DarioHealth (DRIO) Cash from Investing Activities (2016 - 2025)

DarioHealth filings provide 13 years of Cash from Investing Activities readings, the most recent being -$4.2 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 20023.81% to -$4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.3 million, a 51.4% increase, with the full-year FY2025 number at -$4.3 million, up 51.4% from a year prior.
  • Cash from Investing Activities hit -$4.2 million in Q4 2025 for DarioHealth, down from -$41000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.2 million in Q2 2023 to a low of -$8.9 million in Q1 2024.
  • Median Cash from Investing Activities over the past 5 years was -$128000.0 (2021), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 33586.67% in 2021 and later surged 2728.3% in 2023.
  • DarioHealth's Cash from Investing Activities stood at -$444000.0 in 2021, then skyrocketed by 86.71% to -$59000.0 in 2022, then plummeted by 40.68% to -$83000.0 in 2023, then surged by 74.7% to -$21000.0 in 2024, then crashed by 20023.81% to -$4.2 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$4.2 million (Q4 2025), -$41000.0 (Q3 2025), and -$44000.0 (Q2 2025) per Business Quant data.